Literature DB >> 16759640

Regulation of proliferation and gene expression in cultured human aortic smooth muscle cells by resveratrol and standardized grape extracts.

Zhirong Wang1, Yan Chen, Nazar Labinskyy, Tze-chen Hsieh, Zoltan Ungvari, Joseph M Wu.   

Abstract

Epidemiologic studies suggest that low to moderate consumption of red wine is inversely associated with the risk of coronary heart disease; the protection is in part attributed to grape-derived polyphenols, notably trans-resveratrol, present in red wine. It is not clear whether the cardioprotective effects of resveratrol can be reproduced by standardized grape extracts (SGE). In the present studies, we determined, using cultured human aortic smooth muscle cells (HASMC), growth and specific gene responses to resveratrol and SGE provided by the California Table Grape Commission. Suppression of HASMC proliferation by resveratrol was accompanied by a dose-dependent increase in the expression of tumor suppressor gene p53 and heat shock protein HSP27. Using resveratrol affinity chromatography and biochemical fractionation procedures, we showed by immunoblot analysis that treatment of HASMC with resveratrol increased the expression of quinone reductase I and II, and also altered their subcellular distribution. Growth of HASMC was significantly inhibited by 70% ethanolic SGE; however, gene expression patterns in various cellular compartments elicited in response to SGE were substantially different from those observed in resveratrol-treated cells. Further, SGE also differed from resveratrol in not being able to induce relaxation of rat carotid arterial rings. These results indicate that distinct mechanisms are involved in the regulation of HASMC growth and gene expression by SGE and resveratrol.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16759640     DOI: 10.1016/j.bbrc.2006.05.156

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

1.  Cardioprotection by resveratrol: a review of effects/targets in cultured cells and animal tissues.

Authors:  Joseph M Wu; Tze-Chen Hsieh; Zhirong Wang
Journal:  Am J Cardiovasc Dis       Date:  2011-04-27

Review 2.  Are sirtuins viable targets for improving healthspan and lifespan?

Authors:  Joseph A Baur; Zoltan Ungvari; Robin K Minor; David G Le Couteur; Rafael de Cabo
Journal:  Nat Rev Drug Discov       Date:  2012-06-01       Impact factor: 84.694

3.  Endothelial Nrf2 activation: a new target for resveratrol?

Authors:  György Haskó; Pál Pacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-05-14       Impact factor: 4.733

Review 4.  Small heat shock proteins in smooth muscle.

Authors:  Sonemany Salinthone; Manoj Tyagi; William T Gerthoffer
Journal:  Pharmacol Ther       Date:  2008-05-16       Impact factor: 12.310

5.  Resveratrol prevents hypoxia-induced arginase II expression and proliferation of human pulmonary artery smooth muscle cells via Akt-dependent signaling.

Authors:  Bernadette Chen; Jianjing Xue; Xiaomei Meng; Jessica L Slutzky; Andrea E Calvert; Louis G Chicoine
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-06-20       Impact factor: 5.464

Review 6.  Resveratrol: Biological and pharmaceutical properties as anticancer molecule.

Authors:  Tze-chen Hsieh; Joseph M Wu
Journal:  Biofactors       Date:  2010 Sep-Oct       Impact factor: 6.113

Review 7.  Resveratrol in cardiovascular disease: what is known from current research?

Authors:  Hong Wang; Yue-Jin Yang; Hai-Yan Qian; Qian Zhang; Hui Xu; Jian-Jun Li
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

8.  Comparative effects of flavonoids on oxidant scavenging and ischemia-reperfusion injury in cardiomyocytes.

Authors:  Wei-Tien Chang; Zuo-Hui Shao; Jun-Jie Yin; Sangeeta Mehendale; Chong-Zhi Wang; Yimin Qin; Juan Li; Wen-Jone Chen; Chiang-Ting Chien; Lance B Becker; Terry L Vanden Hoek; Chun-Su Yuan
Journal:  Eur J Pharmacol       Date:  2007-03-30       Impact factor: 4.432

Review 9.  Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence.

Authors:  Joao Tomé-Carneiro; Mar Larrosa; Antonio González-Sarrías; Francisco A Tomás-Barberán; María Teresa García-Conesa; Juan Carlos Espín
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

10.  Resveratrol improves cardiac function by promoting M2-like polarization of macrophages in mice with myocardial infarction.

Authors:  Shuiyuan Liu; Yingqiang Du; Kexin Shi; Yaqing Yang; Zhijian Yang
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.